No writing assistance was utilized in the production of this manuscript. The combined use of antiplatelet drugs acting through different mechanisms is important in antithrombotic treatment of ...

Intermittent fasting may reduce the risk of blood clots and cardiovascular disease by inhibiting platelet activation.

The mode of action of aspirin as an antiplatelet agent is through an irreversible ... the Society for Cardiovascular Angiography and Interventions Drug-eluting Task Force published an excellent ...

The antiplatelet drug has been recommended for approval by the US regulator's cardiovascular and renal drugs advisory committee, which voted 10-1 in favour. The anticlotting agent would be the ...

The fields of pharmacology and dentistry have long been intertwined. Medications prescribed for heart conditions — such as ...

The Prescription Drug User Fee Act (PDUFA) date refers to the deadline set by the US Food and Drug Administration (FDA) for reviewing a New Drug Application (NDA) or Biologics License Application (BLA ...

With no differences between single or dual antiplatelet therapy or anticoagulants at 6 months, an RCT is warranted for ...

Bentracimab is an investigational human monoclonal antibody fragment that binds to ticagrelor, an oral P2Y 12 platelet inhibitor, reversing its antiplatelet effects. The BLA submission is ...